Loracarbef

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Loracarbef
Loracarbef.png
Clinical data
Trade names Lorabid
AHFS/Drugs.com Monograph
MedlinePlus a601206
ATC code
Pharmacokinetic data
Protein binding 25%
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
Formula C16H16ClN3O4
Molar mass 349.769 g/mol
3D model (Jmol)
 NYesY (what is this?)  (verify)

Loracarbef is an antibiotic.[1] It is a carbacephem, but it is sometimes grouped together with the second-generation cephalosporin antibiotics. Loracarbef is a synthetic "carba" analog of cefaclor, and is more stable chemically.

History[edit]

Loracarbef received FDA approval in 1991 and it was marketed under the trade name Lorabid. Its use was discontinued in 2006.[citation needed]

Side effects[edit]

Diarrhea is the most common adverse effect with loracarbef. Side effects are more frequently seen with children under the age of twelve.

References[edit]

External links[edit]